\n\n\n \n \n\n \n \n \n \n\n\n \n\n \n\n Nov 13, 2009 6:53 AM EST \n\n \n AnalystChoice.com Initiates Research on SSRI, PLCE, SVNT, ARUN, STSI and TQNT - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Nov 04, 2009 7:23 PM EST \n\n \n Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Nov 04, 2009 5:30 AM EST \n\n \n RothmanResearch.com Market Review and Company Analysis on SYNA, ARUN, CELG, SVNT, PRGN and SWHC - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Oct 28, 2009 6:32 PM EDT \n\n \n Savient Pharmaceuticals to Hold Third Quarter 2009 Financial Results Conference Call on Thursday, November 5, 2009 - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Oct 27, 2009 4:31 PM EDT \n\n \n Savient Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference - GlobeNewswire\n \n \n | \n\n \n\n \n\n \n\n Oct 26, 2009 7:10 AM EDT \n\n \n WallStSense.com Offers Detailed Analysis on DWA, SVNT, ATVI, SSRI, CIEN and AVNR - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Oct 15, 2009 11:22 AM EDT \n\n \n Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option - PR Newswire\n \n \n | \n\n \n\n \n | \n
\n\n
\n\n");